Clinical Trials Directory
We are doing this study to evaluate the safety and performance of a medical technology called the Medtronic Hugo® RAS system (the study device) in hernia repair robotic assisted surgery (RAS) procedures.
If you agree to be in the study, you will have 1 study visit that will last about 4 hours.
The visit will include asking questions about your medical history, vital signs, pulmonary function tests (PFTs) and an MRI (magnetic resonance image) of the chest with inhaled Xenon gas.
Someone from the study team will contact you about 24 hours after your study visit.
We are doing this study to find out if an experimental drug called eltrekibart (the study drug) is a safe and effective option for moderate to severe hidradenitis suppurativa (HS).
We are doing this study to test a new intervention for people with type 1 diabetes who also have disordered eating. We hope the strategy we are testing in this study can improve diabetes management and decrease eating disorder symptoms and emotional distress.
We are doing this study to find the most effective, safe dose of an experimental drug called iberdomide (the study drug). We want to know how well this study drug works in people with multiple myeloma when compared with a drug called lenalidomide after an autologous stem cell transplant.
This study is a biorepository (storehouse) where samples and data from critically ill patients with COVID-19 are stored.
The reason for this study is to develop a collection of samples and data that can be shared with other doctors and researchers to help them answer important questions about the virus and possibly help develop treatments and tests for the future.
Este estudio es un registro central para guardar información y muestras de pacientes críticamente enfermos en una Unidad de Cuidados Intensivos (ICU) que tienen COVID-19
El objetivo de este estudio es crear una colección de información y muestras que pueda ser compartida con otros médicos y otros investigadores para ayudar a responder preguntas importantes sobre el virus, y posiblemente desarrollar tratamientos y pruebas de detección en el futuro.
The purpose of this study is to understand the safety of IDE196 when given before and after treatment.
We are doing this study to compare the outcomes of people who get their after-transplant care in the hospital versus in their home. This study is important to learn if getting after-transplant care in a patient's home can lead to better outcomes.